New Insights Into MicroRNA in Dermatological Diseases
August 2025
in “
Frontiers in Medicine
”
Studysummary This review discusses the roles of microRNAs (miRs) in dermatological diseases and suggests they could be promising targets for innovative skin disease treatments, although further research is needed for clinical application.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
MicroRNAs (miRs) are non-coding RNA molecules that play a crucial role in regulating gene expression and are involved in various physiological processes. They are being explored as biomarkers and therapeutic targets for dermatological diseases such as psoriasis, skin wounds, systemic sclerosis, skin tumors, and systemic lupus erythematosus. MiRs influence skin pathophysiology through mechanisms like oxidative stress, inflammation, apoptosis, and angiogenesis. Understanding miRs and their regulatory targets is vital for advancing skin disease treatment. While miRs combined with new materials may offer innovative therapies, more research is needed to translate these findings into clinical applications.
